Black Bird Biotech Inc (BBBT)
0.0001
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Black Bird Biotech Gross Profit Margin (Quarterly): 36.02% for Sept. 30, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 36.02% |
| June 30, 2023 | 54.10% |
| March 31, 2023 | 45.85% |
| December 31, 2022 | 12.52% |
| September 30, 2022 | 51.98% |
| June 30, 2022 | 39.71% |
| March 31, 2022 | 42.25% |
| December 31, 2021 | 4.08% |
| September 30, 2021 | 15.18% |
| June 30, 2021 | 33.01% |
| March 31, 2021 | 31.08% |
| December 31, 2020 | -314.3% |
| September 30, 2020 | 56.49% |
| June 30, 2020 | 68.86% |
| March 31, 2020 | 33.39% |
| December 31, 2019 | |
| September 30, 2019 | 29.94% |
| June 30, 2019 | -47.98% |
| March 31, 2019 | -748.5% |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | |
| September 30, 2017 |
| Date | Value |
|---|---|
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | 7.69% |
| June 30, 2011 | 7.15% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-314.3%
Minimum
Dec 2020
68.86%
Maximum
Jun 2020
11.31%
Average
33.39%
Median
Mar 2020
Gross Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | 68.19% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Assets | -533.7% |
| Profit Margin (Quarterly) | -3.33K% |
| Operating Margin (Quarterly) | -276.5% |
| Return on Net Operating Assets | -666.0% |